Patent · US Expired

Antisense inhibition of replication protein a p70 subunit

US6309882A · kind A · utility

0Cited by
2References
13Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 10, 1999
Grant dateOct 30, 2001
Priority date
Expiry dateSep 10, 2019

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/582
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods are provided for modulating the expression of the replication protein A p70 subunit and for the treatment and diagnosis of diseases associated with replication protein A p70 subunit.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.